General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
London capital markets have been surprisingly active in 2023, right? | proactiveinvestors.co.uk • |
MDA Breakout Stocks/ETFs Week 12 - March 2023: High-Frequency Gainers To Give You An Edge | seekingalpha.com • |
Week 27 MDA Breakout Stocks - July 2022: Short-Term Picks To Give You An Edge | seekingalpha.com • |
Week 15 MDA Breakout Stocks - April 2022: Short-Term Picks To Give You An Edge | seekingalpha.com • |
Week 13 MDA Breakout Stocks - April 2022: Short-Term Picks To Give You An Edge | seekingalpha.com • |
Week 11 MDA Breakout Stocks - March 2022: Short-Term Picks To Give You An Edge | seekingalpha.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2021-11-12 | 2021-09 | -0.19 | N/A | N/A | N/A |
2021-08-13 | 2021-06 | -0.16 | N/A | N/A | N/A |
2021-05-07 | 2021-03 | -0.18 | N/A | N/A | N/A |
2021-03-18 | 2020-12 | -0.14 | N/A | N/A | N/A |
2020-11-16 | 2020-09 | -0.14 | N/A | N/A | N/A |
2020-08-12 | 2020-06 | -0.06 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2021-08-24 | Craig-Hallum | Downgrade | Buy | Hold |
2021-08-24 | JMP Securities | Downgrade | Market Outperform | Market Perform |
2021-08-23 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
2021-04-14 | Benchmark | Upgrade | Buy | |
2020-11-18 | HC Wainwright & Co. | Upgrade | Buy | |
2020-10-12 | Evercore ISI Group | Upgrade | Outperform |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2021-01-07 | PARSONS, JAMES TODD | Chief Financial Officer | 0.00 | Sale |
2021-04-07 | PETROVA PENKA | Officer | 0.00 | Sale |
2021-05-11 | SKVARKA JAN PH.D. | Chief Executive Officer | 0.00 | Sale |
2021-07-06 | UGER ROBERT | Officer | 0.00 | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2021-09-29 | Blackrock Inc. | 6.11M | 107.34M | 5.82% |
2021-09-29 | NEA Management Company, LLC | 5.74M | 100.73M | 5.46% |
2021-09-29 | Avoro Capital Advisors LLC | 5.70M | 100.09M | 5.43% |
2021-09-29 | Eventide Asset Management LLC | 5.23M | 91.79M | 4.98% |
2021-09-29 | Magnetar Financial LLC | 3.27M | 57.45M | 3.12% |
2021-09-29 | Pentwater Capital Management Lp | 3.14M | 55.14M | 2.99% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2021-06-29 | Mutual Fund Ser Tr-Eventide Healthcare & Life Sciences Fund | 9.51M | 92.25M | 9.06% |
2021-09-29 | iShares Russell 2000 ETF | 2.30M | 40.35M | 2.19% |
2021-09-29 | iShares Russell 2000 Value ETF | 915.11K | 16.07M | 0.87% |
2021-07-30 | Franklin Strategic Series-Franklin Biotechnology Discove | 884.02K | 5.77M | 0.84% |
2021-08-30 | Fidelity Small Cap Index Fund | 746.25K | 12.86M | 0.71% |
2021-07-30 | Franklin Strategic Series-Franklin Small Cap Growth Fund | 717.90K | 4.69M | 0.68% |
Split | Date |
---|---|
1 : 30 | 2014-11-20 |
1 : 10 | 2013-02-06 |
Yeah, so shorts and spammers seem to be running free and loose here today...
3000 shares is not executive dumping. Sometimes people take a little profit along the way - especially when they have more options...
I’ve sold many times more than that and still have a giant pile of shares (0.37 avg...love this stock!)
$TRIL will this stock move up soon or should I keep my phone upside down?
What’s the source of the Merck rumor?
It’s interesting that out of all the combo therapy studies announced, they are continuing with one mono therapy study (primary t-cell lymphoma) because “there are no good agents available” to treat in combo...
Not just bullish as an investor - this is an exciting time to watch cancer therapies evolve!
Predictions:
April 28 - 622 data readout, multiple combo therapy stage 3 trials announced.
Price goes to 20-50$ a share.
May 1 - buyout offer.
May 2 - I pay off my mortgage.
PT for conference:
I think announcement of 622 results alone is going to be a major catalyst, but it was surmised/intimated that combo studies would be announced/discussed that day - expanded solid tumor application, etc. I believe that solidly puts tril at the stage where 47inc was when they took off.
As such, I’m very bullish that this carries us up to 20-40$ range, which will be a buyout zone.
$TRIL Circuit breaks down to 8% 🤬 just bought 1000 shares at $3 level in long run I will okay, hope so. Remember 2008? It breaks 3 times within month! But after all win win who bought at cheap low. Don’t panic patients always wins
$TRIL Seattle already test first drug but for approval that going take months or two. Mass laid off unfortunately started or all companies freeze hiring. Instead of help people they laying off.